Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

The ABC-HCC Trial: A Phase IIIb, randomized, multicenter, open-label trial of Atezolizumab plus Bevacizumab versus transarterial Chemoemboli… Recruiting

2024-512953-26-00 intermediate-stage hepatocellular carcinoma 5 2021-07-06
Investigate the efficacy and safety of a bio-marker driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RA… Recruiting

2024-518534-81-00 metastatic colorectal cancer 4 2021-07-01
Roll Over Study for Patients Who Have Completed a Previous Oncology Study with Olaparib Recruiting

2024-512982-15-00 BRCA Mutated Ovarian Cancer Patients, Epithelian ovaria 5 2021-06-28
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Subcutaneous Glofitamab following Obinutuz… Recruiting

2023-507728-22-00 Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma 3 2021-06-25
Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cance… Recruiting

2024-515344-23-00 local advenced pancreatic adenocarcinoma 4 2021-06-17
Comparison of Cyclophosphamide and doxorubicin as a first line treatment in elderly patients with metastatic sarcoma Recruiting

2024-510653-10-00 Advanced or metastatic soft tissue sarcoma (STS) in pat 5 2021-06-04
Role of [68Ga]Ga-FAPI PET/CT in oncological patients with doubtful or inconclusive findings at [18F]F-FDG PET/CT Recruiting

2024-518765-96-00 oncological disease suspicion/ new diagnosis or with a 4 2021-06-03
An early phase clinical trial to investigate EO2463, a novel cancer vaccine therapy, in patients with indolent Non-Hodgkin's Lymphoma. Recruiting

2023-509254-58-00 Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma; M 7 2021-05-31
To check the safety, efficacy and tolerability of the drug vemurafenib, and to determine the duration of treatment in children with BRAF mut… Recruiting

2024-515805-25-00 histiocytic cell proliferation 4 2021-05-13
Phase 2, Open label Study of DS-1062a, an Anti-TROP-2-Antibody-Drug Conjugate (ADC), in patients with advanced and/or unresectable Non-Small… Recruiting

2023-505924-71-00 Adult patients with metastatic and/or unresectable Non- 4 2021-05-12
Phase 2, Open label Study of Patritumab Deruxtecan (U3-1402), an Anti-HER3-Antibody Drug Conjugate (ADC), in patients with Advanced Breast C… Recruiting

2023-505923-30-00 Patients with hormone-receptor positive (HR+) and human 4 2021-05-11
TIME AND MOTION STUDY OF A SUBCUTANEOUS FIXED DOSE COMBINATION OF PERTUZUMAB AND TRASTUZUMAB FOR THE TREATMENT OF PATIENTS WITH HER2-POSITIV… Recruiting

2023-509321-50-00 HER2-POSITIVE EARLY BREAST CANCER 5 2021-04-15
A Phase 2 Study to Evaluate the Efficacy and Safety of MK-1026 in Participants with Hematologic Malignancies Recruiting

2023-504931-42-00 Chronic lymphocytic leukemia/Small lymphocytic lymphoma 4 2021-04-06
Improving public cancer care by implementing precision medicine in Norway Recruiting

2023-507894-16-00 Cancer 4 2021-04-01
Isatuximab in combination with novel agents in RRMM – Master protocol and control arm Recruiting

2024-514988-25-00 Cancer 9 2021-03-31
Isatuximab in combination with SAR445761 (belumosudil) and dexamethasone in relapsed or refractory multiple myeloma Recruiting

2024-514992-16-00 Cancer 9 2021-03-31
Isatuximab in combination with evorpacept and dexamethasone in RRMM Recruiting

2024-514993-38-00 Cancer 9 2021-03-31
AGADIR : Atezolizumab combined with EIK10001 (BDB001) and Immunogenic Radiotherapy in Patients with Advanced Solid Tumors Recruiting

2023-509492-16-00 Adult participants with metastatic (advanced) solid tum 4 2021-03-30
Vaccination with Autologous Dendritic cells loaded with Autologous Tumour homogenate in Glioblastoma: a phase II Study Recruiting

2024-512493-98-00 Glioblastoma 4 2021-03-25
RETINO 2018: conservative treatment for retinoblastoma: efficacy of the new management strategies and visual outcome Recruiting

2024-514025-30-00 Ocular conservative treatment for retinoblastoma 4 2021-03-25
A clinical trial investigating the safety, tolerability, and therapeutic effects of BNT113 in combination with pembrolizumab versus pembroli… Recruiting

2024-512671-12-00 Unresectable head and neck squamous cell carcinoma, met 10 2021-03-05
Sequential neoadjuvant ifosfamide and doxorubicin in localized high-grade soft tissue sarcoma of extremities and trunk wall Recruiting

2023-510185-27-00 Patients with high-grade soft tissue sarcoma of the ext 4 2021-03-01
FIGO 2018 stage IB2 (>2 cm - ≤4 cm ) Cervical Cancer Treated with Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery (CoNteSSa)… Recruiting

2023-507230-24-00 Cervical cancer 4 2021-02-17
Neoadjuvant Immunotherapy with Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) foll… Recruiting

2024-518804-32-00 Non-Small Cell Lung Cancer (NSCLC) 9 2021-02-16